Consent
A written informed consent was obtained from the patient for the
publication of this report.
1. Lee DW, Kim MK, Kim HG. Diagnosis of Pancreatic Neuroendocrine
Tumors. Clin Endosc [Internet]. 2017 [cité 21 oct
2021];50:537‑45. Disponible sur:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5719919/
2. Lawrence B, Gustafsson BI, Chan A, Svejda B, Kidd M, Modlin IM. The
epidemiology of gastroenteropancreatic neuroendocrine tumors. Endocrinol
Metab Clin North Am. 2011;40:1‑18, vii.
3. Mpilla GB, Philip PA, El-Rayes B, Azmi AS. Pancreatic neuroendocrine
tumors: Therapeutic challenges and research limitations. World J
Gastroenterol [Internet]. 2020 [cité 21 oct 2021];26:4036‑54.
Disponible sur: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403797/
4. Oberg K. Genetics and molecular pathology of neuroendocrine
gastrointestinal and pancreatic tumors (gastroenteropancreatic
neuroendocrine tumors). Curr Opin Endocrinol Diabetes Obes.
2009;16:72‑8.
5. Krampitz GW, Norton JA. Pancreatic neuroendocrine tumors. Curr Probl
Surg. 2013;50:509‑45.
6. Halfdanarson TR, Rubin J, Farnell MB, Grant CS, Petersen GM.
Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic
endocrine tumors. Endocr Relat Cancer. 2008;15:409‑27.
7. Berardi R. Neuroendocrine tumors: a multidisciplinary approach for a
complex disease. J Cancer Metastasis Treat [Internet]. 2016 [cité
23 oct 2021];2:277‑8. Disponible sur:
https://jcmtjournal.com/article/view/1664
8. Alkatan H, Ayoubi A. Orbital metastatic primary mediastinal
neuroendocrine tumor: a histopathological case report. Eye Rep
[Internet]. 2012 [cité 21 oct 2021];2:3. Disponible sur:
https://eyereports.org/index.php/eyereports/article/view/eye.2012.e3
9. Harbour JW, De Potter P, Shields CL, Shields JA. Uveal metastasis
from carcinoid tumor. Clinical observations in nine cases.
Ophthalmology. 1994;101:1084‑90.
10. Radu E, Saizu A, Grigorescu R, Croitoru A, Gheorghe C. Metastatic
neuroendocrine pancreatic tumor – Case report. J Med Life
[Internet]. 2018 [cité 22 oct 2021];11:57‑61. Disponible sur:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909947/
11. Roshan D. A Case of a Large Non-Functional Pancreatic Neuroendocrine
Tumor: A Case Report and a Review of the Literature. Gen Surg. 2020;5:4.
12. Cloyd JM, Poultsides GA. Non-functional neuroendocrine tumors of the
pancreas: Advances in diagnosis and management. World J Gastroenterol
WJG [Internet]. 2015 [cité 22 oct 2021];21:9512‑25. Disponible
sur: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4548112/
13. Dasari A, Shen C, Halperin D, Zhao B, Zhou S, Xu Y, et al. Trends in
the Incidence, Prevalence, and Survival Outcomes in Patients With
Neuroendocrine Tumors in the United States. JAMA Oncol. 2017;3:1335‑42.
14. Riihimäki M, Hemminki A, Sundquist K, Sundquist J, Hemminki K. The
epidemiology of metastases in neuroendocrine tumors. Int J Cancer.
2016;139:2679‑86.
15. Eckhauser FE, Cheung PS, Vinik AI, Strodel WE, Lloyd RV, Thompson
NW. Nonfunctioning malignant neuroendocrine tumors of the pancreas.
Surgery. 1986;100:978‑88.
16. Peixoto RD, Lim HJ, Cheung WY. Neuroendocrine tumor metastatic to
the orbit treated with radiotherapy. World J Gastrointest Oncol.
2013;5:177‑80.
17. Ferry AP, Font RL. Carcinoma metastatic to the eye and orbit. I. A
clinicopathologic study of 227 cases. Arch Ophthalmol Chic Ill 1960.
1974;92:276‑86.
18. Sobottka B, Schlote T, Krumpaszky HG, Kreissig I. Choroidal
metastases and choroidal melanomas: comparison of ultrasonographic
findings. Br J Ophthalmol [Internet]. BMJ Publishing Group Ltd; 1998
[cité 21 oct 2021];82:159‑61. Disponible sur:
https://bjo.bmj.com/content/82/2/159
19. Pusceddu S, Milione M, Ortolani S, Pellegrinelli A, Brugia M, Braud
F de, et al. Orbital lesions, an exceedingly rare site of neuroendocrine
tumor metastasis. J Cancer Metastasis Treat [Internet]. 2016 [cité
22 oct 2021];2:341‑4. Disponible sur:
https://jcmtjournal.com/article/view/1562
20. Mathis T, Jardel P, Loria O, Delaunay B, Nguyen A, Lanza F, et al.
New concepts in the diagnosis and management of choroidal metastases.
Prog Retin Eye Res [Internet]. 2019 [cité 22 oct
2021];68:144‑76. Disponible sur:
https://www.sciencedirect.com/science/article/pii/S1350946218300296
21. Borota OC, Kloster R, Lindal S. Carcinoid tumour metastatic to the
orbit with infiltration to the extraocular orbital muscle. APMIS Acta
Pathol Microbiol Immunol Scand. 2005;113:135‑9.
22. Lam M, Lee J, Teoh S, Agrawal R. Choroidal metastasis as the
presenting feature of a non-small cell lung carcinoma with no apparent
primary lesion identified by X-ray: A case report. Oncol Lett.
2014;8:1886‑8.
23. Demirci H, Shields CL, Chao A-N, Shields JA. Uveal metastasis from
breast cancer in 264 patients. Am J Ophthalmol. 2003;136:264‑71.
24. Makabe K, Kurishima K, Shiozawa T, Miyazaki K, Ohara G, Kagohashi K,
et al. Treatment of choroid metastasis from lung adenocarcinoma with
bevacizumab-containing chemotherapy: A case report. Exp Ther Med
[Internet]. Spandidos Publications; 2016 [cité 23 oct
2021];11:239‑42. Disponible sur:
https://www.spandidos-publications.com/10.3892/etm.2015.2893
25. Hernández-Ayuso I, Rodríguez-Reyes AA, Ríos y Valles-Valles D,
Kawakami-Campos PA, Herrera Cifuentes SL. Just another metastatic
carcinoid tumour to the uveal tract. Saudi J Ophthalmol [Internet].
2018 [cité 21 oct 2021];32:355‑7. Disponible sur:
https://www.sciencedirect.com/science/article/pii/S1319453418300493
26. Valenzuela AA, Archibald CW, Fleming B, Ong L, O’Donnell B, Crompton
J J, et al. Orbital metastasis: clinical features, management and
outcome. Orbit Amst Neth. 2009;28:153‑9.
27. Bloch RS, Gartner S. The Incidence of Ocular Metastatic Carcinoma.
Arch Ophthalmol. 1971;85:673‑5.
28. Riddle PJ, Font RL, Zimmerman LE. Carcinoid tumors of the eye and
orbit: a clinicopathologic study of 15 cases, with histochemical and
electron microscopic observations. Hum Pathol. 1982;13:459‑69.
29. Mehta JS, Abou-Rayyah Y, Rose GE. Orbital carcinoid metastases.
Ophthalmology. 2006;113:466‑72.
30. Caplin ME, Buscombe JR, Hilson AJ, Jones AL, Watkinson AF, Burroughs
AK. Carcinoid tumour. Lancet Lond Engl. 1998;352:799‑805.
31. Shields CL, Shields JA, Eagle RC, Peyster RG, Conner BE, Green HA.
Orbital metastasis from a carcinoid tumor. Computed tomography, magnetic
resonance imaging, and electron microscopic findings. Arch Ophthalmol
Chic Ill 1960. 1987;105:968‑71.
32. Rosset A, Zografos L, Coucke P, Monney M, Mirimanoff RO.
Radiotherapy of choroidal metastases. Radiother Oncol J Eur Soc Ther
Radiol Oncol. 1998;46:263‑8.
33. Rush JA, Waller RR, Campbell RJ. Orbital carcinoid tumor metastatic
from the colon. Am J Ophthalmol. 1980;89:636‑40.
34. Fan JT, Ortiz RG, Buettner H. Regression of choroidal metastases
from a bronchial carcinoid tumor after chemotherapy with cisplatin and
etoposide. Am J Ophthalmol. 1994;117:111‑3.
35. Moertel CG, Kvols LK, O’Connell MJ, Rubin J. Treatment of
neuroendocrine carcinomas with combined etoposide and cisplatin.
Evidence of major therapeutic activity in the anaplastic variants of
these neoplasms. Cancer. 1991;68:227‑32.
36. Isidori AM, Kaltsas G, Frajese V, Kola B, Whitelocke R a. F, Plowman
PN, et al. Ocular metastases secondary to carcinoid tumors: the utility
of imaging with [(123)I]meta-iodobenzylguanidine and
[(111)In]DTPA pentetreotide. J Clin Endocrinol Metab.
2002;87:1627‑33.
37. Letson AD, Davidorf FH, Bruce RA. Chemotherapy for Treatment of
Choroidal Metastases from Breast Carcinoma. Am J Ophthalmol.
1982;93:102‑6.